Qube Research & Technologies (QRT)
LYEL icon

Qube Research & Technologies (QRT)’s Lyell Immunopharma LYEL Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio LYEL Stock Details LYEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.55M Buy
110,531
+55,421
+101% +$1M ﹤0.01% 2231
2026
Q1 		$1.11M Buy
55,110
+46,059
+509% +$1.08M ﹤0.01% 2440
2025
Q4 		$279K Buy
+9,051
New +$203K ﹤0.01% 2970
2024
Q1 		– Sell
-425
Closed -$16.5K – 4707
2023
Q4 		$16.5K Buy
+425
New +$15.3K ﹤0.01% 3518
2022
Q1 		– Sell
-563
Closed -$87K – 2770
2021
Q4 		$87K Buy
+563
New +$126K ﹤0.01% 2165
2021
Q3 		– Sell
-2,275
Closed -$739K – 2546
2021
Q2 		$739K Buy
+2,275
New +$746K 0.01% 1075

Other funds holding LYEL

AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OPL
Orland Properties Ltd Road Town, Tortola, British Virgin Islands $202M AUM 2.79% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $417M AUM 22.81% 1-Year Est. Return
FCMV
Foresite Capital Management V Larkspur, California $362M AUM 386.37% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

Qube Research & Technologies (QRT)'s LYEL Position: Q2 2026 in Review

Qube Research & Technologies (QRT) increased its Lyell Immunopharma (LYEL) stake by 101% in Q2 2026, buying an estimated $1M and bringing the position to 110,531 shares worth $1.55M. The position accounts for ﹤0.01% of the portfolio, ranked #2231.

Qube Research & Technologies (QRT) first reported a position in LYEL in Q2 2021 and has held it in 6 quarters since. 87 funds tracked by Wall St. Rank hold LYEL as of Q2 2026.

  • Qube Research & Technologies (QRT) held 110,531 shares of Lyell Immunopharma worth $1.55M as of Q2 2026.
  • Qube Research & Technologies (QRT) bought 55,421 Lyell Immunopharma shares in Q2 2026, an estimated $1M.
  • Lyell Immunopharma made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #2231 holding.
  • Qube Research & Technologies (QRT) first reported a position in Lyell Immunopharma in Q2 2021 and has held it in 6 quarters since.
  • 87 funds tracked by Wall St. Rank held Lyell Immunopharma as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.